Shamaazi, Ltd – Trademark Portfolio

Entity Type: 99

Shamaazi, Ltd holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include GIVEMATCH, MY10NIGHTS, MYTENNIGHTS, and NEVER MISS LAYLATUL QADR. The owner is based in London.

36 Alie Street

London E18DA , GB

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shamaazi, Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (7 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Shamaazi, Ltd have?

Shamaazi, Ltd has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 abandoned.

What trademark classes does Shamaazi, Ltd file in?

Shamaazi, Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Shamaazi, Ltd's most well-known trademarks?

Shamaazi, Ltd's registered trademark portfolio includes well-known marks such as GIVEMATCH, MY10NIGHTS, MYTENNIGHTS, and NEVER MISS LAYLATUL QADR. These are among 4 currently registered trademarks in the portfolio.

What is Shamaazi, Ltd's trademark registration success rate?

Shamaazi, Ltd has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.